Why You Should Track Calories If You Want to Lose Weight
Posted on
January 20th 2025
(5 months)
SHARE
Get the full length version of this episode as a podcast.
This episode will make a great companion for a long drive.
The Omega-3 Supplementation Guide
A blueprint for choosing the right fish oil supplement — filled with specific recommendations, guidelines for interpreting testing data, and dosage protocols.
In this video, Rhonda Patrick & Layne Norton discuss:
- Why people hoping to lose weight should start tracking calories (for at least 3 days)
- Common revelations when people start tracking calories
- Why most people lie to themselves about food intake
- Why self-deception is at the heart of most "slow metabolisms" — according to science
- The difference between lean mass & skeletal muscle mass
- How a seemingly healthy salad can end up being 600+ calories
Member only extras:
FoundMyFitness Members get access to exclusive content not available anywhere else. This
episode comes with a helpful quick reference
presentation slide deck
filled with all of the graphics and figures from the video.
Learn more about the advantages of a premium membership by clicking below.
Are you already a member?
Sign in here.
Get email updates with the latest curated healthspan research
Support our work
Every other week premium members receive a special edition newsletter that summarizes all of the latest healthspan research.
Weight loss News
- Lifestyle instability: an overlooked cause of population obesity?
- Artificial sweetener sucralose may disrupt the brain's appetite regulation by mimicking sweetness without increasing blood sugar, leading to increased hunger and altered brain activity.
- Omega-3 supplementation combined with exercise improves body composition and cardiometabolic health more effectively than exercise alone, including a notable 10% decrease in triglyceride levels.
- Intermittent fasting three nonconsecutive days per week coupled with regular exercise promotes more weight loss than daily calorie restriction.
- GLP-1 receptor agonists may lower risks for major illnesses like dementia and seizures.
